Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William R Greco

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2005
Cyclosporin A is a broad-spectrum multidrug resistance modulatorMisbah Qadir, Kieran L O'Loughlin, Stacy M Fricke, et al.
Leukemia Research|April 8, 2004
Expression of the neural cell adhesion molecule CD56 is not associated with P-glycoprotein overexpression in core-binding factor acute myeloid leukemiaAttaya Suvannasankha, Hans Minderman, Kieran L O'Loughlin, et al.
American Journal of Clinical Oncology|February 11, 2003
Lymphoma of the nasal cavity and paranasal sinuses: treatment and outcome of early-stage diseaseGary M Proulx, Ivone Caudra-Garcia, Judith Ferry, et al.
Cancer Research|April 19, 2003
Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patientsDavid A Bellnier, William R Greco, Gregory M Loewen, et al.
British Journal of Haematology|November 4, 2004
Breast cancer resistance protein (BCRP/MXR/ABCG2) in adult acute lymphoblastic leukaemia: frequent expression and possible correlation with shorter disease-free survivalAttaya Suvannasankha, Hans Minderman, Kieran L O'Loughlin, et al.
Cancer Chemotherapy and Pharmacology|July 13, 2005
Sequential administration of irinotecan and cytarabine in the treatment of relapsed and refractory acute myeloid leukemiaHans Minderman, Kieran L O'Loughlin, Patrick F Smith, et al.
Antimicrobial Agents and Chemotherapy|February 28, 2007
Modeling the combination of amphotericin B, micafungin, and nikkomycin Z against Aspergillus fumigatus in vitro using a novel response surface paradigmYseult F Brun, Carly G Dennis, William R Greco, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2006
Effect of amphotericin B and micafungin combination on survival, histopathology, and fungal burden in experimental aspergillosis in the p47phox-/- mouse model of chronic granulomatous diseaseCarly G Dennis, William R Greco, Yseult Brun, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2005
Cyclosporin A is a broad-spectrum multidrug resistance modulatorMisbah Qadir, Kieran L O'Loughlin, Stacy M Fricke, et al.
Leukemia Research|April 8, 2004
Expression of the neural cell adhesion molecule CD56 is not associated with P-glycoprotein overexpression in core-binding factor acute myeloid leukemiaAttaya Suvannasankha, Hans Minderman, Kieran L O'Loughlin, et al.
American Journal of Clinical Oncology|February 11, 2003
Lymphoma of the nasal cavity and paranasal sinuses: treatment and outcome of early-stage diseaseGary M Proulx, Ivone Caudra-Garcia, Judith Ferry, et al.
Cancer Research|April 19, 2003
Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patientsDavid A Bellnier, William R Greco, Gregory M Loewen, et al.
British Journal of Haematology|November 4, 2004
Breast cancer resistance protein (BCRP/MXR/ABCG2) in adult acute lymphoblastic leukaemia: frequent expression and possible correlation with shorter disease-free survivalAttaya Suvannasankha, Hans Minderman, Kieran L O'Loughlin, et al.
Cancer Chemotherapy and Pharmacology|July 13, 2005
Sequential administration of irinotecan and cytarabine in the treatment of relapsed and refractory acute myeloid leukemiaHans Minderman, Kieran L O'Loughlin, Patrick F Smith, et al.
Antimicrobial Agents and Chemotherapy|February 28, 2007
Modeling the combination of amphotericin B, micafungin, and nikkomycin Z against Aspergillus fumigatus in vitro using a novel response surface paradigmYseult F Brun, Carly G Dennis, William R Greco, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2006
Effect of amphotericin B and micafungin combination on survival, histopathology, and fungal burden in experimental aspergillosis in the p47phox-/- mouse model of chronic granulomatous diseaseCarly G Dennis, William R Greco, Yseult Brun, et al.
Pageof 3